Results 41 to 50 of about 28,108,623 (169)

Community Experience With Pediatric‐Inspired Regimens for Acute Lymphoblastic Leukemia in Adolescent and Young Adults

open access: yesCancer Medicine, Volume 15, Issue 7, July 2026.
ABSTRACT Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) are a growing population with unfavorable outcomes relative to pediatric peers. Historic underrepresentation in prospective studies has complicated unifying recommendations surrounding optimal therapeutic strategy for this group.
Matthew T. Newman   +4 more
wiley   +1 more source

Prognostic factors for clinical outcomes of patients with central nervous system leukemia

open access: yesHematology/Oncology and Stem Cell Therapy, 2021
Prognostic factors associated with clinical outcomes of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients with central nervous system (CNS) involvement are unknown. We retrospectively studied the characteristics and outcomes of
Jinai Bharucha   +10 more
doaj   +1 more source

CHANGE

open access: yes, 2013
CHANGE is a multi-faceted programme which seeks to transform the way lone parents think about food. The programme focuses on education, health and the affordability of healthy food for lone parents, as a particularly disadvantaged low-income group.
Healthy Food For All
core   +1 more source

Plasma calprotectin to assess susceptibility to bloodstream infections during paediatric acute lymphoblastic leukaemia induction treatment

open access: yesBritish Journal of Haematology, Volume 208, Issue 4, Page 1339-1346, April 2026.
Summary Chemotherapy‐induced neutropenia, monitored by peripheral blood absolute neutrophil count (ANC), increases the risk of bloodstream infections (BSIs). However, ANC may not reflect the total neutrophil population, as it omits neutrophils at extravascular sites.
Johanna Vævest Nymann Eriksen   +9 more
wiley   +1 more source

Ponatinib: A drug review

open access: yesCancer Research, Statistics, and Treatment, 2019
The discovery of Philadelphia (Ph) chromosome in 1959 was a landmark moment in the history of targeted therapies for cancer. The BCR-ABL fusion gene formed as a result of this translocation is the key pathogenetic event of chronic myeloid leukemia (CML ...
Hasmukh Jain   +3 more
doaj   +1 more source

The Breakfast Club

open access: yes, 2013
The Breakfast Club was set up in January 2013. The aim of the breakfast club is to provide pupils with breakfast in a safe, structured and warm environment at the beginning of each school day so as to enhance their - Concentration- Attendance and ...
Healthy Food For All
core   +1 more source

PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia

open access: yesHematology, 2022
Objectives The high frequency of chemotherapy resistance is ultimately responsible for clinical relapse in acute lymphoblastic leukemia (ALL). Nevertheless, the molecular mechanism relevant to glucocorticoid (GC) resistance remains ambiguous.
Pei-Ye Hui   +3 more
doaj   +1 more source

Limerick Seed to Plate

open access: yes, 2013
The aim of the project is to address an identified need in the community, promoting healthy eating and organic home-gardening practices. Building on the success of a pilot intergenerational project entitled "Through the Years", it became apparent that ...
Healthy Food For All
core   +1 more source

Targeting the Menin–KMT2A interaction in leukemia: Lessons learned and future directions

open access: yesInternational Journal of Cancer, Volume 158, Issue 2, Page 342-356, 15 January 2026.
Abstract Chromosomal rearrangements involving the Mixed Lineage Leukemia gene (MLL1, KMT2A) are defining a genetically distinct subset in about 10% of human acute leukemias. Translocations involving the KMT2A‐locus at chromosome 11q23 are resulting in the formation of a chimeric oncogene, where the N‐terminal part of KMT2A is fused to a variety of ...
Florian Perner   +3 more
wiley   +1 more source

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia—A Retrospective, Dual‐Center Study

open access: yesAmerican Journal of Hematology, Volume 101, Issue 1, Page 16-25, January 2026.
ABSTRACT Survival outcomes for adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) have improved with modern frontline therapies and minimal residual disease (MRD)‐guided strategies. As a result, allogeneic hematopoietic cell transplantation (HCT) is increasingly deferred in first remission (CR1) and used in the relapsed setting.
Oren Pasvolsky   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy